These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17168080)

  • 21. Melatonin--a possible link between sleep and the immune system.
    Haimov I; Shochat T; Lavie P
    Isr J Med Sci; 1997 Apr; 33(4):246-50. PubMed ID: 9347872
    [No Abstract]   [Full Text] [Related]  

  • 22. Selegiline and vitamin E in Alzheimer's disease.
    Adelman A
    J Fam Pract; 1997 Aug; 45(2):98-100. PubMed ID: 9267360
    [No Abstract]   [Full Text] [Related]  

  • 23. Complementary and alternative medicines patients are talking about: melatonin.
    Lee CO
    Clin J Oncol Nurs; 2006 Feb; 10(1):105-7. PubMed ID: 16482735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What are the prospects of slowing the progression of Alzheimer's disease?
    Palmer AM
    Drug Discov Today; 2012 Nov; 17(21-22):1157-9. PubMed ID: 23036820
    [No Abstract]   [Full Text] [Related]  

  • 25. A review of antioxidants and Alzheimer's disease.
    Frank B; Gupta S
    Ann Clin Psychiatry; 2005; 17(4):269-86. PubMed ID: 16402761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Melatonin: myth or reality?].
    Valero N
    Invest Clin; 1998 Dec; 39(4):253-5. PubMed ID: 9927800
    [No Abstract]   [Full Text] [Related]  

  • 27. Circadian system functionality, hippocampal oxidative stress, and spatial memory in the APPswe/PS1dE9 transgenic model of Alzheimer disease: effects of melatonin or ramelteon.
    Baño Otalora B; Popovic N; Gambini J; Popovic M; Viña J; Bonet-Costa V; Reiter RJ; Camello PJ; Rol MÁ; Madrid JA
    Chronobiol Int; 2012 Aug; 29(7):822-34. PubMed ID: 22823866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotection: promise and pitfalls in anti-inflammatory treatment of Alzheimer's disease.
    Memo M; Blandini F; Nappi G; Spano P
    Funct Neurol; 2002; 17(4):175-6. PubMed ID: 12675259
    [No Abstract]   [Full Text] [Related]  

  • 29. Melatonin: circadian rhythm regulator, chronobiotic, antioxidant and beyond.
    Berra B; Rizzo AM
    Clin Dermatol; 2009; 27(2):202-9. PubMed ID: 19168001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alzheimer's disease and antioxidant therapy: how long how far?
    Teixeira J; Silva T; Andrade PB; Borges F
    Curr Med Chem; 2013; 20(24):2939-52. PubMed ID: 23409717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Melatonin: use and abuse].
    Puigdevall Gallego V; Laudo Pardos C
    Med Clin (Barc); 1997 Sep; 109(8):297-9. PubMed ID: 9379752
    [No Abstract]   [Full Text] [Related]  

  • 32. Mounting a defence against Alzheimer's disease.
    Ross M
    CMAJ; 1999 Mar; 160(6):773. PubMed ID: 10189410
    [No Abstract]   [Full Text] [Related]  

  • 33. Melatonin and sleep in aging population.
    Pandi-Perumal SR; Zisapel N; Srinivasan V; Cardinali DP
    Exp Gerontol; 2005 Dec; 40(12):911-25. PubMed ID: 16183237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monozygotic twins with Alzheimer's disease treated with melatonin: Case report.
    Brusco LI; Márquez M; Cardinali DP
    J Pineal Res; 1998 Dec; 25(4):260-3. PubMed ID: 9885996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic approaches to cognitive deficits in Alzheimer's disease.
    Peskind ER
    J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of rivastigmine in Alzheimer's disease. Participation in trials should be based on clinical uncertainty, not enforcement.
    Bullock R; Passmore P; Wilkinson D; Howard R; Jones R
    BMJ; 2000 Feb; 320(7233):511-2. PubMed ID: 10678874
    [No Abstract]   [Full Text] [Related]  

  • 37. Melatonin and cardiovascular disease: myth or reality?
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Reiter RJ
    Rev Esp Cardiol (Engl Ed); 2012 Mar; 65(3):215-8. PubMed ID: 22245066
    [No Abstract]   [Full Text] [Related]  

  • 38. [Melatonin. Physiology and clinical applications].
    Cardinali DP
    Vertex; 2007; 18(74):288-93. PubMed ID: 18219402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rivastigmine for Alzheimer's disease.
    Drug Ther Bull; 2000 Feb; 38(2):15-6. PubMed ID: 10829350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melatonin plus physical exercise are highly neuroprotective in the 3xTg-AD mouse.
    García-Mesa Y; Giménez-Llort L; López LC; Venegas C; Cristòfol R; Escames G; Acuña-Castroviejo D; Sanfeliu C
    Neurobiol Aging; 2012 Jun; 33(6):1124.e13-29. PubMed ID: 22177720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.